Paper Example: Public Health Interventions - Chronic Kidney Disease Initiative

Date:  2021-04-07 07:50:22
2 pages  (560 words)
Back to categories
This essay has been submitted by a student. This is not an example of the work written by our professional essay writers.
Vanderbilt University
Type of paper: 
This essay has been submitted by a student. This is not an example of the work written by our professional essay writers.

The Chronic Kidney Disease (CKD) program is designed to offer a comprehensive public health technique meant for promoting kidney health. These strategies are intended to control and prevent the primary risk factors associated with CKD, increase awareness, improve quality and outcome of life as well as to enhance early CKD dialysis. Moreover, the CKD program provides technical consultant and assistant in the developing the healthy people 2020 objectives (Ogletree, Frinak, Soman, & Yee, 2006). Chronic Kidney disease and end-stage renal disease (ESRD) are the current leading public health challenges being faced by the United States as well as other sources of poor quality and suffering of life or the affected. These types of diseases are responsible for premature deaths and results to high economic costs for both public and private sectors. The primary objective of Chronic Kidney Disease intervention is to reduce the new cases of CKD, complications, deaths, disability and the economic costs. Chronic Kidney Disease response is necessary for meeting the healthy people 2020 objectives as this may result in improved quality and longer lives for individuals with CKD, eradication of disparities among CKD patients and reduction of CKD burden (Soman & Yee, 2006).

The objectives of Chronic Kidney Disease intervention programs include:

To reduce the number of people in the US with CKD,

To increase awareness to individuals with Chronic Kidney disease and make them know they have impaired renal function,

To increase the number of hospital patients with acute kidney injuries and who have a follow-up renal evaluation within six months post discharge,

To increase the proportion of patients with CKD and diabetes and who are under medical evaluation recommendation,

Improving the cardiovascular care in patients with chronic kidney disease,

Reduce the rate of kidney failure as a result of diabetes.

Ensure that hemodialysis patients have access to vascular treatment.

Reduce the rates of casualties in patients with end-stage renal disease (ESRD).

Over the last several years, research has demonstrated that proteinuria- excess protein in the urine- has resulted to faster progression of kidney diseases to ERSD mostly in diabetic patients. Today, diabetes is the main causing agent of kidney failure. According to the outcomes of Diabetes Prevention Program that was founded by the National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) shows that a healthy diet, weight reduction, and exercises have possibilities of preventing the development of type 2 diabetes. These interventions, guidelines and community-based programs are consistent with the Chronic Kidney Disease 2020 objectives (Soman & Yee, 2006). Moreover, both ethnic and racial groups have equally benefited from the new lifestyles of the modified programs. In addition, communities and other voluntary organizations around the United States have started programs that are aimed at ensuring that there is a healthier living to prevent and reduces cases of diabetes.

Other emerging issues are closely related to Chronic Kidney Disease. For instance, a section of ESRD patients under kidney transplant after three years of registration has substantially declined over the past decade. This decline is resulted by the unavailability of transplantation organs. This condition has prompted to the foundation of an advisory committee by the U.S department of health and human services to address the challenge (Soman & Yee, 2006).


Ogletree, N., Frinak, S., Soman, S., & Yee, J. (2006). Chronic Kidney Disease (CKD) clinic improves management of cardiovascular disease (CVD) risk factors in CKD. Advances in Chronic Kidney Disease, 13(2), 193. doi:10.1053/j.ackd.2006.01.020



Request Removal

If you are the original author of this essay and no longer wish to have it published on the ProEssays website, please click below to request its removal: